Mature aggressive B-cell lymphoma across age groups – molecular advances and therapeutic implications-Reference-Cited by-同舟云学术

Mature aggressive B-cell lymphoma across age groups – molecular advances and therapeutic implications

Published:2016-12-26 Issue:2 Volume:10 Page:123-135
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Lange Jonas¹²,Lenz Georg²,Burkhardt Birgit¹

Affiliation:

1. Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany

2. Translational Oncology, Department of Medicine A, University Hospital Muenster, Muenster, Germany; Cluster of Excellence EXC 1003, Cells in Motion, Muenster, Germany

Funder

Clinician-Scientist Program of the Cells-in-Motion Cluster of Excellence

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2017.1271318

Reference117 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence

3. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project.

4. Pathogenesis of Non-Hodgkin's Lymphoma

5. Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The kava chalcone flavokawain B exerts inhibitory activity and synergizes with BCL-2 inhibition in malignant B-cell lymphoma;Phytomedicine;2023-11

2. An immune risk score predicts survival of patients with diffuse large B-cell lymphoma;Leukemia Research;2023-02

3. Clinical and prognostic effect of MYC protein score in patients with diffuse large B-cell lymphoma in relation to blood group secretor status;The Egyptian Journal of Haematology;2023

4. Multiple blood parameters may serve as a warning to immunochemotherapy-related interstitial lung disease in B-cell lymphoma;Annals of Palliative Medicine;2021-09

5. Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas;Frontiers in Oncology;2019-06-04